Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Ethical considerations raised by the approval of interferon beta‐1b for the treatment of multiple sclerosis
Home
Publications
Ethical considerations raised by the approval of interferon beta‐1b for the treatment of multiple sclerosis
Ethical considerations raised by the approval of interferon beta‐1b for the treatment of multiple sclerosis
Authors:
DG
Donald E. Goodkin
Donald E. Goodkin
GK
George A. Kanoti
George A. Kanoti
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
1 January 1994
journal article
Published by
Wolters Kluwer Health
in
Neurology
Vol. 44
(1)
,
166
DOI:
10.1212/wnl.44.1.166
PMID:
8290058
Abstract
No abstract available
Keywords
BIOMEDICAL AND BEHAVIORAL RESEARCH
CLEVELAND CLINIC FOUNDATION
PROFESSIONAL PATIENT RELATIONSHIP
Cited
Cited by 8 articles
Scroll to top